| アブストラクト | BACKGROUND: Depression and anxiety during pregnancy is on the rise, thus more pregnant women are being offered antidepressants; however, uncertainties remain surrounding safety. AIM: To investigate the association between first trimester antidepressant use and miscarriage. DESIGN AND SETTING: Population-based cohort study using the UK Clinical Practice Research Datalink (CPRD) GOLD. METHOD: Pregnancies included in the CPRD GOLD Pregnancy Register between 1996 and 2018 were identified. Pregnancies in those with prescriptions for antidepressants overlapping with the first trimester were defined as 'exposed' and compared with pregnancies in those who were unexposed. Cox models, adjusted hazard ratios (aHRs), and absolute risk of miscarriage were calculated adjusted for confounders including depression, anxiety, smoking, and other health, lifestyle, and obstetric factors. RESULTS: Among the 1 021 384 eligible pregnancies, 73 540 patients were prescribed antidepressants in the first trimester (7.2%); 10 693/73 540 (14.5%) pregnancies ended in miscarriage among those prescribed antidepressants versus 116 641/947 844 (12.3%) in those not prescribed antidepressants. Antidepressant prescription during the first trimester was only modestly associated with miscarriage following adjustment (aHR 1.04, 95% confidence interval [CI] = 1.02 to 1.06). These findings translated to an absolute risk adjusted for confounders of 13.1% (95% CI = 13.0 to 13.2) for those not prescribed and 13.6% (95% CI = 13.3 to 13.8) for those prescribed antidepressants. Among those prescribed antidepressants in the 3 months before pregnancy and during the first trimester, the risk of miscarriage was the same as among those unexposed (aHR 1.00, 95% CI = 0.98 to 1.03). CONCLUSION: First trimester antidepressant use was associated with a small, clinically insignificant increased risk of miscarriage, with no evidence suggesting taking antidepressants before pregnancy and into the first trimester increases the risk of miscarriage. |
| 投稿者 | Martin, Florence Z; Madley-Dowd, Paul C; Ahlqvist, Viktor H; Sharp, Gemma C; Easey, Kayleigh E; Lee, Brian K; Merriel, Abi; Rai, Dheeraj; Forbes, Harriet |
| 組織名 | Medical Research Council Integrative Epidemiology Unit, Bristol Medical School,;University of Bristol, Bristol, UK flo.martin@bristol.ac.uk.;Population Health Sciences, Bristol Medical School, University of Bristol,;Bristol, UK.;Centre for Academic Mental Health, Bristol Medical School, University of Bristol,;University of Bristol, Bristol, UK.;NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston;NHS Foundation Trust and University of Bristol, Bristol, UK.;Department of Biomedicine, Aarhus University, Aarhus, Denmark.;Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.;School of Psychology, University of Exeter, Exeter, UK.;School of Psychological Science, University of Bristol, Bristol, UK.;AJ Drexel Autism Institute, Drexel University, Philadelphia, PA, US.;Department of Epidemiology and Biostatistics, Drexel University Dornsife School;of Public Health, Philadelphia, PA, US.;Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.;Women's and Children's Health, Institute of Life Course and Medical Sciences,;University of Liverpool, Liverpool, UK.;Department of Non-communicable Disease Epidemiology, London School of Hygiene and;Tropical Medicine, London, UK. |